BB Healthcare Trust PLC (LON:BBH) portfolio manager Paul Major discusses with Proactive London's Andrew Scott how the fund's been performing, his near-term expectations as well as general investor sentiment in the healthcare space.
In the six months ended 31 May – the first half of BB Healthcare’s financial year – the company enjoyed another period of relative outperformance, meaning it outperformed the benchmark index over the same period.
Major describes the recent summer months as 'painful' - mainly down to the performance of two stocks - Illumina and Align.
Currently, around 20% of the fund is made up of mega caps that are worth upwards of US$50bn.
Another 28% or so is big caps (over US$10bn), while small and mid-caps (sub-US$10bn) account for just over half of the investments.